[62] The mystery of gross haematuria in a patient on leflunomide: A case report and literature review

Objective: To report a case of gross haematuria in a patient on leflunomide. In 1998, the USA Food and Drug Administration approved leflunomide for the treatment of active rheumatoid arthritis. Leflunomide is classified as a disease-modifying anti-rheumatic drug (DMARD), which has immunomodulatory,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vincent Khor, Kwok Ying Lie
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2018
Materias:
Acceso en línea:https://doaj.org/article/ac67fb1fcf304d33a374d1cb6e0ee89f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!